Bruker Cellular Analysis, Inc.
CELLDelisted Oct 2, 2023- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001689657
Bruker Cellular Analysis, Inc. was delisted on Oct 2, 2023; its insiders filed their last Form 4 on Oct 3, 2023; 57 institutions reported holding it in 13F filings for Q3 2023, worth $35.8M in total; no superinvestor held it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 57
- Q3 2023, −27 vs. previous quarter
- 13F value
- $35.8M
- Reported value at the end of Q3 2023
- Superinvestors holding
- 0
- At the end of Q3 2023
Superinvestors holding CELL, Q3 2023
No superinvestor reported holding CELL at the end of Q3 2023.
Latest insider trades
Open-market purchases and sales by Bruker Cellular Analysis, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 24, 2022 (view filing) | Oct 20 | 4 days | McClaskey James PaulSVP, Chief Accounting Officer | SSale | −122 | $1.99 | −$242.78 | −0.2%67.2K after | |
| May 23, 2022 (view filing) | May 13 | 10 days | Hobbs Ericsee Remarks | SSale | −6.20K | $4.97 | −$30.8K | −3.3%184.1K after | Amended |
| May 13, 2022 (view filing) | May 11-12 | 2 days | Hobbs Ericsee Remarks | SSale | −221.1K | $4.25 | −$940.1K | −53.7%190.3K after | Amended2 lots |
| Mar 15, 2022 (view filing) | Mar 11 | 4 days | Chiminski John RDirector | PPurchase | +18.0K | $5.18 | +$93.2K | +367.3%22.9K after | |
| Mar 15, 2022 (view filing) | Mar 11 | 4 days | Lucier Gregory TDirector | PPurchase | +50.0K | $5.24 | +$262.0K | +18.2%324.3K after | |
| Mar 11, 2022 (view filing) | Mar 10 | 1 day | Hopfield JessicaDirector | PPurchase | +80.0K | $6.28 | +$502.4K | +827.1%89.7K after | |
| Nov 10, 2021 (view filing) | Nov 8 | 2 days | Rothman JamesDirector | PPurchase | +4.00K | $24.35 | +$97.4K | +2.9%144.2K after | |
| Nov 9, 2021 (view filing) | Nov 5 | 4 days | Lucier Gregory TDirector | PPurchase | +20.7K | $24.15 | +$500.0K | +8.2%274.3K after | |
| Sep 16, 2021 (view filing)5:29 PM ET | Sep 14 | 2 days | Breinlinger KeithChief Technical Officer | SSale | −4.00K | $33.28 | −$133.1K | −9.3%39.1K after | 2 lots |
| Sep 9, 2021 (view filing) | Sep 7-9 | 2 days | Khandros Igor YDirector, 10% Owner | SSale | −75.0K | $36.61 | −$2.75M | −0.8%8.99M after | 4 lots |
Top 10 13F holders, Q3 2023
The largest institutional positions in Bruker Cellular Analysis, Inc. at the end of Q3 2023; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Beryl Capital Management LLC | 9,829,722 | $9.81M | 1.25% | +9,829,722 | New |
| Mackenzie Financial Corp | 4,152,031 | $4.14M | 0.01% | 00.0% | Unchanged |
| Glenview Capital Management, LLC | 3,816,313 | $3.81M | 0.10% | 00.0% | Unchanged |
| Vanguard Group Inc | 3,519,033 | $3.51M | 0.00% | +39,449+1.1% | Added |
| Swedbank AB | 2,500,000 | $2.50M | 0.00% | 00.0% | Unchanged |
| Terrapin Asset Management, LLC | 2,109,863 | $2.11M | 2.89% | +2,109,863 | New |
| Gardner Lewis Asset Management L P | 1,696,854 | $1.69M | 0.62% | +1,696,854 | New |
| Crystalline Management Inc. | 1,211,994 | $1.21M | 0.92% | +1,199,902+9,923.1% | Added |
| SC US (TTGP), Ltd. | 1,166,480 | $1.16M | 0.01% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 1,069,428 | $1.07M | 0.00% | −477,235−30.9% | Reduced |